Skip to main content
IDXX logo

IDXX · Idexx Laboratories Inc /De

$544.32 +4.96 (+0.92%) At close · Jul 24
Market Cap
$42.94B
Shares
78.88M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Jonathan Mazelsky $14,580,122
Michael J. Lane $4,019,416
Tina Hunt $3,945,293
Martin Smith $3,944,534
Andrew Emerson $3,033,071
Brian McKeon $351,680
Fiscal 2024
Executive Total
Jonathan Mazelsky $13,007,051
Brian McKeon $3,892,748
Tina Hunt $3,730,700
Michael J. Lane $3,726,323
Martin Smith $3,719,059
Fiscal 2023
Executive Total
Jonathan Mazelsky $11,519,309
Brian McKeon $3,845,065
Tina Hunt $3,570,793
Michael J. Lane $2,921,361
James F. Polewaczyk $2,917,036
Martin Smith
Fiscal 2022
Executive Total
Jonathan Mazelsky $9,788,388
Brian McKeon $3,510,826
Michael J. Lane $2,541,191
James F. Polewaczyk $2,540,086
Tina Hunt $2,537,863
Martin Smith
Fiscal 2021
Executive Total
Jonathan Mazelsky $9,065,021
Brian McKeon $3,625,035
James F. Polewaczyk $2,592,975
Michael J. Lane $2,592,658
Tina Hunt $2,583,105
Fiscal 2020
Executive Total
Jonathan Mazelsky $7,038,175
Brian McKeon $3,350,185
James F. Polewaczyk $2,105,700
Michael J. Lane $1,909,005
Sharon E. Underberg $1,881,117
Tina Hunt
Fiscal 2019
Executive Total
Jonathan W. Ayers $8,188,764
Jonathan Mazelsky $7,419,335
Brian McKeon $3,940,306
Kathy V. Turner $2,696,822
Sharon E. Underberg $1,809,228
Michael J. Lane $1,473,880
James F. Polewaczyk
Tina Hunt
Fiscal 2018
Executive Total
Jonathan W. Ayers $6,819,950
Brian McKeon $2,905,934
Jonathan Mazelsky $2,897,125
Kathy V. Turner $1,935,853
Michael J. Lane $1,357,675
Sharon E. Underberg
James F. Polewaczyk
Fiscal 2017
Executive Total
Jonathan W. Ayers $6,665,351
Brian McKeon $2,422,971
Jonathan Mazelsky $2,269,833
Kathy V. Turner
Sharon E. Underberg
Michael J. Lane
Key facts CIK 874716 CUSIP 45168D104 13F (30d) 337 filings 330 filers Visit website Investor relations